Perrigo Company (PRGO) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
3 Apr, 2026Voting matters and shareholder proposals
Clarification provided for Proposal 4 regarding amendments to the Long-Term Incentive Plan (LTIP), specifically on share recycling rules for Options and Stock Appreciation Rights.
Upon shareholder approval of the 2026 LTIP, no new awards will be made under the current equity compensation plan.
Executive compensation and say-on-pay
The supplement details how shares used for tax withholding or purchase price for Options and Stock Appreciation Rights will not be recycled for future awards under the 2026 LTIP.
Shares tendered or withheld for awards other than Options or Stock Appreciation Rights may be added back to the plan's share pool.
Shareholder rights and capital structure
Shareholders are informed they may change or revoke their proxy votes if desired, following the instructions in the Proxy Statement.
Latest events from Perrigo Company
- Transformation and innovation drive growth and recovery in a resilient global healthcare market.PRGO
Canaccord Genuity's 46th Annual Growth Conference - Q2 2026 sales and margins fell, but market share gains and debt reduction support a positive outlook.PRGO
Q2 2026 - Q1 2026 saw lower sales and a $330.8M goodwill impairment, but market share gains and outlook reaffirmed.PRGO
Q1 2026 - Gained OTC market share, delivered cost savings, and targets growth through innovation and efficiency.PRGO
UBS Global Consumer and Retail Conference - Adjusted EPS up 7% to $2.75; FY2026 outlook cautious but expects second-half recovery.PRGO
Q4 2025 - Q3 2025 saw OTC share gains despite sales decline and a downward revision of FY2025 outlook.PRGO
Q3 2025 - Q3 2024 delivered margin expansion, higher adjusted EPS, and infant formula market share gains.PRGO
Q3 2024 - Margin gains and cost savings offset lower sales, supporting reaffirmed 2024 EPS guidance.PRGO
Q2 2024 - Adjusted EPS up 106.9% and margins expanded, despite lower net sales.PRGO
Q1 2025